Evidence map›Paper›PMID 29410444›Full record

ArticleNature communications2018

Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe

Hou-Fu Guo, Chi-Lin Tsai, Masahiko Terajima, Xiaochao Tan, Priyam Banerjee, Mitchell D Miller, Xin Liu, Jiang Yu, Jovita Byemerwa, Sarah Alvarado and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Collagen IV biosynthesis: Intracellular choreography of post-translational modifications.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  5. Article
  6. Article
  7. The Crystal Structure ofBiochemistry · 2025
    Article
  8. Structure of an FeActa crystallographica. Section F, Structural biology communications · 2025
    Article
  9. Article
  10. Article
  11. Iron and Cancer.Advances in experimental medicine and biology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Modeling of Protein Complexes.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  16. Super-enhanced MARCO variant drives triple-negative breast cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Review
  19. Article
  20. A FeFrontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Hou-Fu GuoDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-3659-9399
Chi-Lin TsaiDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-0365-2405
Masahiko TerajimaNorth Carolina Oral Health Institute, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.ORCID http://orcid.org/0000-0002-1502-7930
Xiaochao TanDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Priyam BanerjeeDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Mitchell D MillerDepartment of Biosciences, Rice University, Houston, TX, 77251, USA.ORCID http://orcid.org/0000-0003-1626-4943
Xin LiuDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jiang YuDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jovita ByemerwaDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Sarah AlvaradoDepartment of Biosciences, Rice University, Houston, TX, 77251, USA.
Tamer S KaoudDivision of Medicinal Chemistry, Targeted Therapeutic Drug Discovery and Development Program, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA.
Kevin N DalbyDivision of Medicinal Chemistry, Targeted Therapeutic Drug Discovery and Development Program, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78712, USA.
Neus Bota-RabassedasDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Yulong ChenDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Mitsuo YamauchiNorth Carolina Oral Health Institute, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
John A TainerDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jtainer@mdanderson.org.ORCID http://orcid.org/0000-0003-1659-2429
George N PhillipsDepartment of Biosciences, Rice University, Houston, TX, 77251, USA. georgep@rice.edu.
Jonathan M KurieDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jkurie@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USRice University · USAustin College · USUniversity of North Carolina at Chapel Hill · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
HOUSTON AREA MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008280 · NIGMS · RICE UNIVERSITY · PI WENSEL, THEODORE G · 1988 to 2023
$8.0M
Regulation of Lung Cancer Metastasis by a Procollagen Lysine HydroxylaseR01CA105155 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KURIE, JONATHAN M · 2004 to 2019
$4.0M
Regulation of eEF-2K an Energy and Nutrient SensorR01GM123252 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI DALBY, KEVIN N, GHOSE, RANAJEET · 2017 to 2024
$2.7M
Mechanism and Specificity of MAP KinasesR01GM059802 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI DALBY, KEVIN N · 2001 to 2011
$2.3M
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)R01GM105404 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TAINER, JOHN A. · 2012 to 2015
$2.1M
A Pixel Array Detector System for Small Angle X-ray ScatteringS10OD018483 · OD · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CLASSEN, SCOTT · 2014 to 2014
$998k
Collagen Glycosylation, Maturation and MineralizationR21AR060978 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YAMAUCHI, MITSUO · 2012 to 2013
$352k
NCI NIH HHS P50 CA070907NCI NIH HHS R01 CA105155NIAMS NIH HHS R21 AR060978NIGMS NIH HHS P30 GM124169NIGMS NIH HHS R01 GM059802NIGMS NIH HHS R01 GM105404NIGMS NIH HHS R01 GM123252NIGMS NIH HHS T32 GM008280NIH HHS S10 OD018483
6 · The paper itself

Abstract

Collagen lysyl hydroxylases (LH1-3) are Fe

Indexed as

Protein MultimerizationAmino Acid SequenceAnimalsCatalytic DomainCell Line, TumorCollagenCrystallography, X-RayEnzyme StabilityHumansIronLung NeoplasmsMice, NudeMimiviridaeMutationNeoplasm MetastasisProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseCollagenIronProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseViral Proteins

Identifiers

PMID29410444
PMCPMC5802723
OpenAlexW2787989014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.